Artificial Intelligence (AI) is revolutionizing the world, particularly the Life Sciences domain. Be it large leaps that we have taken in the field of genomics research and drug discovery or large language models such as ChatGPT, which is making inroads into traditionally less-automated areas such as medical transcriptions – one area which remains sheltered from the exponential benefits of Artificial Intelligence (AI) is the domain of Regulatory Intelligence (RI).
It is surprising, given how critical and ubiquitous Regulatory Intelligence is across the Life Sciences industry- be it pharmaceuticals or medical devices or even consumer goods such as cosmetics and food supplements.
A recent third-party survey* (https://gens-associates.com/2023/05/01/regulatory-intelligence-2022-study-whitepaper/) has revealed that less than 30% of the organizations have put AI to good use, while only 17% have harnessed the power of AI to automate day-to-day RI tasks. Thus, organizations still have to rummage through tons of documents (most of which will become obsolete in no time), spend countless hours to derive that one critical insight and bear the brunt of ballooning technology and consultant costs as they go global.
There is always a risk that something will slip through the gap, leading to unforeseen compliance costs, reputation loss from product recalls, and unacceptably long timelines for market expansion.
Can AI plug this gap? In this blog, we shall explore some of the key shortcomings of the RI space and the key use cases where AI can be put to good use.
With ChatGPT on the horizon, it might seem enticing that these challenges will be resolved! But we know AI hallucinates and ChatGPT is a black-box tool that does not provide a direct reference to the source of information. In a domain with very little margin of error and a strong need for information traceability, such drawbacks would render the garden variety of ChatGPT to be of not much value.
At Freyr, we understand the challenges of this journey. Therefore, at every step, we are not using AI for AI, but we are trying to solve customer problems.
Step 1 - Data Collection: Intelligent web-scraping bots.
Step 2 - Data Curation: Auto-translators and auto-summarizers trained on Regulatory ontology.
Step 3 - Data Analysis: Decision tree based on decades worth of precedence data and AWS Quicksight with rich, easy-to-use, cost-effective managed dashboards (Expert-curated dashboards).
Step 4: Data Consumption: Context-trained and context-aware ChatGPT.
While AI has revolutionized various domains, RI has remained relatively untouched by its benefits, with only a very small percentage of organizations harnessing AI for RI tasks.
By employing intelligent web-scraping bots, auto-translators, summarizers, advanced visualizations, and context-trained ChatGPT, Freyr aims at providing effective RI solutions. Dive into a world of cutting-edge technology and witness firsthand the remarkable capabilities of Freyr’s dedicated RI platform – Freyr Freya.Intelligence. Request a demo!
Don't miss out on this incredible opportunity to explore the future of regulatory intelligence.
Get your regulatory dose of information delivered straight to your inbox every month!
Subscribe NowSay goodbye to hours spent on Regulatory research, with our AI powered Regulatory Advisor. Get verified Regulatory information from Health authorities across 150+ countries.
Unlock efficiency with Freya,
your Regulatory time saver!